Icon Advisers Inc. Co. trimmed its stake in shares of HCA Healthcare Inc (NYSE:HCA) by 26.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 62,500 shares of the company’s stock after selling 22,600 shares during the period. Icon Advisers Inc. Co.’s holdings in HCA Healthcare were worth $5,490,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in HCA. Atlantic Trust LLC purchased a new stake in shares of HCA Healthcare during the second quarter valued at $118,000. BB&T Investment Services Inc. purchased a new stake in HCA Healthcare in the 2nd quarter worth about $141,000. Kovack Advisors Inc. purchased a new stake in HCA Healthcare in the 4th quarter worth about $234,000. Massey Quick Simon & CO. LLC purchased a new stake in HCA Healthcare in the 3rd quarter worth about $251,000. Finally, Checchi Capital Advisers LLC purchased a new stake in HCA Healthcare in the 4th quarter worth about $267,000. 74.89% of the stock is owned by institutional investors and hedge funds.

Shares of HCA Healthcare Inc (HCA) opened at $97.84 on Friday. HCA Healthcare Inc has a one year low of $71.18 and a one year high of $106.84. The company has a debt-to-equity ratio of -6.58, a quick ratio of 1.36 and a current ratio of 1.62. The firm has a market capitalization of $36,030.00, a PE ratio of 16.47, a PEG ratio of 0.96 and a beta of 0.48.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings results on Tuesday, January 30th. The company reported $2.12 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.87 by $0.25. HCA Healthcare had a negative return on equity of 49.49% and a net margin of 4.89%. The company had revenue of $11.56 billion during the quarter, compared to the consensus estimate of $11.19 billion. During the same period last year, the business earned $1.80 EPS. The business’s quarterly revenue was up 8.7% on a year-over-year basis. equities research analysts anticipate that HCA Healthcare Inc will post 8.71 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Friday, March 30th. Stockholders of record on Thursday, March 1st will be paid a dividend of $0.35 per share. This represents a $1.40 dividend on an annualized basis and a dividend yield of 1.43%. The ex-dividend date is Wednesday, February 28th.

Several brokerages recently issued reports on HCA. Zacks Investment Research raised HCA Healthcare from a “hold” rating to a “buy” rating and set a $113.00 price objective for the company in a research note on Friday, February 2nd. Sanford C. Bernstein reissued a “market perform” rating and issued a $116.00 price objective (up from $105.00) on shares of HCA Healthcare in a research note on Thursday, February 1st. BMO Capital Markets increased their price objective on HCA Healthcare from $96.00 to $115.00 and gave the stock an “outperform” rating in a research note on Thursday, February 1st. They noted that the move was a valuation call. Morgan Stanley increased their price objective on HCA Healthcare from $84.00 to $91.00 and gave the stock an “underweight” rating in a research note on Thursday, February 1st. Finally, Royal Bank of Canada increased their price objective on HCA Healthcare to $117.00 and gave the stock an “outperform” rating in a research note on Wednesday, January 31st. Three research analysts have rated the stock with a sell rating, six have given a hold rating and eighteen have given a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus target price of $103.65.

In other news, SVP Joseph A. Sowell III sold 58,175 shares of the stock in a transaction dated Friday, January 26th. The stock was sold at an average price of $95.00, for a total transaction of $5,526,625.00. Following the transaction, the senior vice president now owns 40,536 shares of the company’s stock, valued at approximately $3,850,920. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, SVP Victor L. Campbell sold 8,000 shares of the stock in a transaction dated Thursday, November 16th. The shares were sold at an average price of $75.82, for a total value of $606,560.00. Following the transaction, the senior vice president now directly owns 127,275 shares in the company, valued at approximately $9,649,990.50. The disclosure for this sale can be found here. Insiders have sold a total of 284,469 shares of company stock valued at $28,208,384 over the last ninety days. Company insiders own 2.90% of the company’s stock.

COPYRIGHT VIOLATION WARNING: This news story was originally published by Daily Political and is owned by of Daily Political. If you are accessing this news story on another publication, it was illegally stolen and reposted in violation of United States and international copyright & trademark law. The correct version of this news story can be viewed at https://www.dailypolitical.com/2018/02/10/icon-advisers-inc-co-has-5-49-million-stake-in-hca-healthcare-inc-hca.html.

HCA Healthcare Company Profile

HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare Inc (NYSE:HCA).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.